I guess we will find out the real “effective” rate after we see if people with comorbidities are protected by it. I don’t think they were included in the trials.
46% of study participants in the Pfizer trials had comorbidities: https://www.fda.gov/media/144245/download (page 20).
It’s been tested on them. It works.